Esophageal Crohn's Disease Treated “Topically” with Swallowed Aerosolized Budesonide | Zendy

Petros Zezos | Zendy; Georgios Kouklakis | Zendy; Anastasia Oikonomou | Zendy; Μichail Pitiakoudis | Zendy; Constantinos Simopoulos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Esophageal Crohn's Disease Treated “Topically” with Swallowed Aerosolized Budesonide

Author(s) -

Petros Zezos,

Georgios Kouklakis,

Anastasia Oikonomou,

Μichail Pitiakoudis,

Constantinos Simopoulos

Publication year - 2010

Publication title -

case reports in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.2

H-Index - 20

eISSN - 1687-9627

pISSN - 1687-9635

DOI - 10.1155/2010/418769

Subject(s) - medicine , budesonide , jejunum , gastroenterology , crohn's disease , esophagus , duodenum , concomitant , disease , stomach , ileum , reflux , aerosolization , asthma , anesthesia , inhalation

Proximal Crohn's disease, involving the esophagus, the stomach, the duodenum, and the proximal jejunum, is uncommon. Treatment for proximal Crohn's disease is based on data derived from case series than from controlled trials. We present a case of Crohn's colitis with concomitant proximal esophagogastroduodenal involvement treated with conventional treatment plus swallowed aerosolized budesonide as a novel adjuvant topical treatment for the esophageal disease, and we review the treatment options for proximal Crohn's disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research